1. Home
  2. TV vs PVLA Comparison

TV vs PVLA Comparison

Compare TV & PVLA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Grupo Televisa S.A.

TV

Grupo Televisa S.A.

HOLD

Current Price

$2.89

Market Cap

1.6B

Sector

Industrials

ML Signal

HOLD

Logo Palvella Therapeutics Inc.

PVLA

Palvella Therapeutics Inc.

HOLD

Current Price

$126.77

Market Cap

1.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TV
PVLA
Founded
1969
2015
Country
Mexico
United States
Employees
26551
14
Industry
Broadcasting
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.6B
1.6B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
TV
PVLA
Price
$2.89
$126.77
Analyst Decision
Buy
Strong Buy
Analyst Count
4
15
Target Price
$5.30
$171.87
AVG Volume (30 Days)
1.5M
173.2K
Earning Date
05-12-2026
05-12-2026
Dividend Yield
2.83%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$104,350.18
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.67
$20.20
52 Week High
$3.49
$151.18

Technical Indicators

Market Signals
Indicator
TV
PVLA
Relative Strength Index (RSI) 43.11 51.21
Support Level $2.86 $108.99
Resistance Level $2.94 $135.23
Average True Range (ATR) 0.14 6.37
MACD -0.03 -0.66
Stochastic Oscillator 21.95 31.09

Price Performance

Historical Comparison
TV
PVLA

About TV Grupo Televisa S.A.

Televisa is one of the leading telecom firms in Mexico. Its cable arm, Izzi, holds networks that pass 20 million Mexican homes and provide broadband service to nearly 6 million customers. The firm is also one of the largest pay-television providers in Mexico, with nearly 4 million customers. Televisa owns Sky Mexico, the country's only satellite-TV provider, serving about 4 million customers. After merging its traditional media business into Univision, Grupo Televisa owns a 43% stake in the combined entity TelevisaUnivision. Grupo Televisa spun off several smaller businesses, including magazine publishing, three of Mexico's professional soccer teams, and Azteca Stadium in February 2024, under the name Ollamani.

About PVLA Palvella Therapeutics Inc.

Palvella Therapeutics Inc is a late clinical-stage biopharmaceutical company committed to serving individuals suffering from serious, rare genetic skin diseases without approved therapies. The Company's lead product candidate, QTORIN 3.9 percent rapamycin anhydrous gel (QTORIN rapamycin), is based on the Company's patented QTORIN platform. QTORIN rapamycin is in clinical development for two rare genetic skin disorders.

Share on Social Networks: